SUL-238, Identical to test product except without active substance
GN-002
Phase 2 small_molecule active
Quick answer
SUL-238, Identical to test product except without active substance for Parkinson’s Disease is a Phase 2 program (small_molecule) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sana Biotechnology
- Indication
- Parkinson’s Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active